Chief Commercial Officer
Mr. Lo joined Puma Biotechnology as its Chief Commercial Officer in September 2015. As Chief Commercial Officer, Mr. Lo is responsible for leading the Company’s commercial operations. Prior to joining the Company, he held a number of positions at Corcept Therapeutics Incorporated from September 2010 to September 2015, including Senior Vice President, Oncology and Senior Vice President & Chief Commercial Officer.
Prior to Corcept, Mr. Lo was with Genentech, Inc. from December 1997 to September 2010. At Genentech, Mr. Lo held a number of positions, including Senior Director, Oncology Marketing, where he prepared and led the first U.S. launch of Herceptin® in adjuvant HER2 positive breast cancer and also worked with Genentech’s then ex-U.S. marketing partner, Roche, to develop the global adjuvant launch strategy for Herceptin® in adjuvant HER2 positive breast cancer.
Mr. Lo received a B.S. in Microbiology from the University of California, Davis and a Master of Health Administration from the University of Southern California.
Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024